Internal Server Error

About Delaware Crossing Investor Group

Delaware Crossing Investor Group, established in 2005, is an angel investment group based in Warrington Township, United States. It primarily focuses on Seed investments in companies in United States. Its portfolio includes 11 firms, spanning the Enterprise Applications, FinTech sectors. Its most notable investments include companies like Thubrikar Aortic Valve, Novira Therapeutics and Hulafrog. As of Oct 2026, Delaware Crossing Investor Group has witnessed 4 portfolio exits. Its latest investment was a Undisclosed Seed round in Vytala on Sep 19, 2024, which also saw participation from Robin Hood Ventures and Ulu Ventures.
To date, 21 investors have co-invested in Delaware Crossing Investor Group's portfolio companies, including prominent names like Robin Hood Ventures.
Key Metrics
Founded Year
2005
Location
Warrington Township, United States
Sectors of Investment
Stages of Investment
Seed & Series A
Locations of Investment

Delaware Crossing Investor Group's List of Top Investments

Delaware Crossing Investor Group has a portfolio of 11 companies. Their most notable investmentis in Life.ioTheir portfolio spans across and United States. They have invested in Enterprise Applications, FinTech, Consumer and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Delaware Crossing Investor Group:
Innovating durable transcatheter aortic valve technology for improved patient outcomes. This company focuses on developing and researching advanced heart valve replacement solutions. Their core offering, the Optimum TAV system, is designed to enhance valve durability and improve the lives of patients with aortic valve disease. They are involved in clinical research and development, presenting their findings at major medical conferences. The company is dedicated to advancing the field of transcatheter aortic valve implantation (TAVI) through technological innovation. Their investigational devices are currently undergoing clinical trials to demonstrate safety and efficacy. They are committed to providing cutting-edge solutions for aortic valve replacement.

Key facts about Thubrikar Aortic Valve

Developer of antiviral therapeutics for the treatment of chronic HBV infections. The company's oral drugs target the capsid of the virus and offer a promising treatment option both as monotherapy and in combination with current standards of care.

Key facts about Novira Therapeutics

  • Founded Year: 2009
  • Location: Radnor (United States)
  • Stage: Acqui-Hired
  • Total Funding till date: $65M
  • Employee Count: 1 as on Sep 30, 2026
  • Investors: Versant Ventures, Canaan and 8 Others
  • Latest Funding Round: Series A, Dec 22, 2014, $*****
  • Highlight: Editors' Pick
Hulafrog, Inc. is a network of hyperlocal sites that help moms find things to do with their kids, including local events, class providers, birthday parties. It is part daily event calendar, part parent-rated business directory available via the web, mobile, and email. With a daily "Our Pick" email and family-friendly deals, Hulafrog acts as a guide to parents with kids in suburban areas.

Key facts about Hulafrog

Life.io is a reward-based platform for monitoring and improving health at an individual level. The platform helps in capturing insights on health and other lifestyle behaviors and help customers connect to the products and services that best suit their needs. It provides a "LifeStyle Score" which brings together biometric, lifestyle and behavioral parameters to provide feedback on a user's daily habits. It also features a community for support.

Key facts about Life.io

Platform offering social media analytics software. The platform enables members to get insights into social media posts and make strategies. It allows members to connect all social media accounts in one place, understand the performance range, and identify what type of content increases engagement and followers. It also helps to make reports to analyze and compare performance.

Key facts about Measure

Delaware Crossing Investor Group's Investments by Stage

Delaware Crossing Investor Group has made 8 investments in Seed stage with an average round size of $1.06M and 3 investments in Series A stage with an average round size of $2.48M.
Here are Delaware Crossing Investor Group's investments by stage:
Stage of entry
No. of Investments
Seed
8
Series A
3
Breakdown of Delaware Crossing Investor Group's investments by stage of entrySeed (8)Series A (3)
Note: We have considered here, only first round of investments

Delaware Crossing Investor Group's Investments by Sector

Delaware Crossing Investor Group has a diverse portfolio, with companies operating in the Enterprise Applications, Life Sciences, Consumer, EdTech and FinTech. Notably, it has invested in 10 Tech companies, 7 Enterprise (B2B) companies, 3 Consumer (B2C) companies and at least 3 companies focusing on Software.
Here are Delaware Crossing Investor Group's investments by sector:
Sector
No. of Investments
Enterprise Applications
4
Life Sciences
4
Consumer
3
EdTech
2
FinTech
2
Others
12
Breakdown of Delaware Crossing Investor Group's investments by sectorsEnterprise Applic... (4)Life Sciences (4)
Note: We have considered here, only first round of investments

Delaware Crossing Investor Group's Investments by Geography

Delaware Crossing Investor Group has made most investments in United States (11).

Delaware Crossing Investor Group's recent investments

Delaware Crossing Investor Group has not made any investment in 2026 so far.
Here are the most recent investments by Delaware Crossing Investor Group:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Sep 19, 2024
United States
Seed
9628
Apr 21, 2023
United States
Seed
5029
Aug 25, 2021
United States
Series A
2053
Feb 13, 2018
United States
Seed
7604
Jan 06, 2016
United States
Seed
7118

Acquired companies in Delaware Crossing Investor Group's Portfolio

4 companies from Delaware Crossing Investor Group's portfolio have been acquired. The most recent acquisition was Hulafrog in Jan 2023 by CertifiKID for $*****.
Here are Delaware Crossing Investor Group's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jan 10, 2023
Jun 04, 2013
Seed
5925
May 21, 2019
Jan 06, 2016
Seed
6757
Nov 04, 2015
Jul 26, 2011
Seed
2936
Nov 09, 2012
Mar 15, 2011
Series A
2768

Co-investors of Delaware Crossing Investor Group

Over the past 18 years, 36 investors have co-invested in Delaware Crossing Investor Group's portfolio companies. This includes funds and angels.

  • Invested before Delaware Crossing Investor Group: BioAdvance, HHS and 5 others have invested in rounds before Delaware Crossing Investor Group. There is 1 company where BioAdvance has invested before Delaware Crossing Investor Group and 1 company where HHS has invested before Delaware Crossing Investor Group.
  • Top Co-investors of Delaware Crossing Investor Group: 21 investors entered a company along with Delaware Crossing Investor Group. These include investors like Robin Hood Ventures (7 companies).
  • Invested after Delaware Crossing Investor Group: A total of 8 investors have invested in Delaware Crossing Investor Group's portfolio after their investments. Top Investors include Labcor (1 company) and Versant Ventures (1 company).

Recent News related to Delaware Crossing Investor Group

•
Noble Midstream and Salt Creek Midstream’s Delaware Basin Joint VentureGlobal Legal Chronicle•Mar 06, 2019•Noble Energy, Delaware Crossing Investor Group
•
Delaware chemical startup amid $1M seed roundThe Business Journals•Feb 21, 2018•Robin Hood Ventures, ThruPore Technologies, Delaware Crossing Investor Group
•
The Business Journals•Novira Therapeutics, Robin Hood Ventures, Delaware Crossing Investor Group, Mid Atlantic Angel Group
View all news related to Delaware Crossing Investor Group

FAQs about Delaware Crossing Investor Group

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford